The police found two homemade Islamic State flags in the car of the suspects, a 50-year-old man and his 24-year-old son.

These are great TV shows that ended early and preserved their quality, including Freaks and Geeks, Pushing Daisies, and My ...

Medtronic has launched the MiniMed 780G system in the U.S., integrated with Abbott’s Instinct sensor technology. Medtronic’s integration with Abbott was just approved by FDA in September, broadening ...

Abbott warned that about 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors are affected, but no other Libre products. Patients can visit FreeStyleCheck.com to see if their sensors are ...

Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...

Claire Danes’ acting chops have been on full display since her star teenage turn in "My So-Called Life." Now that she is 46 and starring in a new Netflix show, "The Beast in Me"—no spoilers; don't ...

Abbott Laboratories shares dipped after announcing a $23 billion acquisition of Exact Sciences, citing concerns over the deal premium and future dilution. Abbott's diversified business, strong organic ...

Two decisions by the Texas governor this week, including directing authorities to investigate an Islamic organization, come as the state sees an increase in anti-Muslim rhetoric. By Ruth Graham Ruth ...

Exact Sciences Corporation stock surged after Abbott Laboratories announces a $21bn acquisition at $105 per share, driven by Exact's cancer diagnostics leadership. Exact Sciences boasts strong revenue ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott Laboratories ABT1.77%increase; green up pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS 0.14%increase; green up pointing triangle in a deal valued at about ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...